Week 10 drugs only Flashcards

Exam 4

1
Q

Characteristic signs and symptoms of asthma:

A

Breathlessness
Tightness in the chest
Wheezing
Dysnea
Cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Underlying cause of asthma:

A

The underlying cause is immune-mediated airway inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic obstructive pulmonary disease (COPD)

A

is a chronic, progressive, largely irreversible disorder characterized by airflow restrictions and inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of COPD

A

Symptoms include chronic cough,
excessive sputum production,
wheezing,
dyspnea, and
poor exercise tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does the inflammatory process of asthma begin?

A

The inflammatory process begins with binding of allergen molecules (e.g., house dust mite feces) to immunoglobulin E (IgE) antibodies on mast cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When allergen molecules bind to IgE antibodies on mast cells in asthma, what happens?

A

This causes mast cells to release an assortment of mediators, including histamine, leukotrienes, prostaglandins, and interleukins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the two effects that mediators released by mast cells have during asthma?

A

These mediators have two effects.

  1. They act immediately to cause bronchoconstriction.
  2. In addition, they promote infiltration and activation of inflammatory cells (eosinophils, leukocytes, macrophages).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do the inflammatory cells do during asthma?

A

These inflammatory cells then release mediators of their own.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the end result of airway inflammation?

A

The end result is airway inflammation characterized by edema, mucus plugging, and smooth muscle hypertrophy, all of which obstruct airflow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In addition to edema, mucus plugging and smooth muscle hypertrophy, what does inflammation produce?

A

Inflammation produces a state of bronchial hyperreactivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms of COPD result largely from a combination of two pathologic processes:

A
  1. chronic bronchitis
  2. emphysema.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chronic bronchitis is defined by:

A

chronic cough and excessive sputum production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does chronic bronchitis result from:

A

results from hypertrophy of mucus-secreting glands in the epithelium of the larger airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Emphysema is defined by:

A

Emphysema is defined as enlargement of the air space within the bronchioles and alveoli brought on by deterioration of the walls of these air spaces.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In a smal percentage of people, emphysema results from:

A

In a small percentage of the population, emphysema results from a genetic alteration that results in alpha-1 antitrypsin deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alpha-1 antitrypsin

A

Alpha-1 antitrypsin is a protease inhibitor that protects the lungs from enzymatic destruction by proteases.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Two main pharmacological classes of drugs for asthma and COPD:

A
  1. Anti inflammatory drugs
  2. Bronchodilators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Principle antiinflammatory drugs are:

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The principal bronchodilators are:

A

beta2 agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

For chronic asthma and stable COPD how are glucocorticoids administered? (route and timing)

A

For chronic asthma and stable COPD, glucocorticoids are administered on a fixed schedule, almost always by inhalation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

For chronic asthma and stable COPD, how are Beta agonists administered?

A

Beta2 agonists may be administered on a fixed schedule (for long-term control) or as needed (PRN; to manage an acute attack). Like the glucocorticoids, beta2 agonists are usually inhaled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Most antiasthma drugs can be administered by inhalation: What are the three advantages of this route?

A

(1) Therapeutic effects are enhanced by delivering drugs directly to their site of action, (2) systemic effects are minimized, and
(3) relief of acute attacks is rapid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MDI

A

are small, handheld, pressurized devices that deliver a measured dose of drug with each actuation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When more than one inhalation is needed for MDIs, how should you take the medication?

A

When two inhalations are needed, an interval of at least 1minute should separate the first inhalation from the second.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Dry Powder Inhalers (DPIs)

A

Dry-powder inhalers (DPIs) are used to deliver drugs in the form of a dry micronized powder directly to the lungs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How do MDIs compare with DPIs?

A
  1. DPIs deliver more drug to the lungs
  2. DPIs are breath activated.
  3. Spacers are not used with DPIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Nebulizer

A

A nebulizer is a small machine used to convert a drug solution into a mist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the most effective drugs available for long term control of airway inflammation?

A

Glucocorticoids (e.g., budesonide, fluticasone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How are glucocorticoids usually administered?

A

Administration is usually by inhalation but may also be IV or oral.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

When do systemic glucocorticoids cause adverse effects?

A

When systemic glucocorticoids are used long term, severe adverse effects are likely.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

In general, what do glucocorticoids do?

A

Glucocorticoids reduce respiratory symptoms by suppressing inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Specific antiinflammatory effects include of glucocorticoids include?

A
  1. Decreased synthesis and release of inflammatory mediators (e.g., leukotrienes, histamine, prostaglandins)
  2. Decreased infiltration and activity of inflammatory cells (e.g., eosinophils, leukocytes)
  3. Decreased edema of the airway mucosa (secondary to a decrease in vascular permeability)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

By reducing inflammation, what do glucocorticoids do?

A
  1. reduce bronchial hyperreactivity and
  2. decrease airway mucus production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Therapeutic use of glucocorticoids:

A

they are especially effective for:
1. asthma prophylaxis and

  1. for management of COPD exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the first line therapy for management of the inflammatory component of asthma?

A

Inhaled glucocorticoids

*most patients with persistent asthma should take these drugs daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Who are oral glucocorticoids required for?

A

May be required for patients with moderate to severe persistent asthma or for management of acute exacerbations of asthma or COPD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is a serious problem with oral glucocorticoids? So when should these drugs be taken? How long should these meds be taken?

A

They have a potential for toxicity.

These drugs are prescribed only when symptoms cannot be controlled with safer medications (inhaled glucocorticoids, inhaled beta2 agonists)

Because the risk for toxicity increases with duration of use, treatment should be as brief as possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Adverse Effects of Inhaled Glucocorticoid:

A
  1. Adrenal suppression
  2. Oropharyngeal candidiasis
  3. Dynsphonia
  4. Slow growth of children and adolescents (but don’t decrease adult height)
  5. Increased risk for glaucoma and cataracts
  6. May promote bone loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Potential adverse effects of prolonged oral glucocorticoids include:

A

adrenal suppression,

osteoporosis,

hyperglycemia,

immunosuppression,

fluid retention,

hypokalemia,

peptic ulcer disease, and,

in young patients, growth suppression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Prolonged glucocorticoid use and adrenal suppression:

A

prolonged glucocorticoid use can decrease the ability of the adrenal cortex to produce glucocorticoids of its own.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

WHy is adrenal suppression life threatening

A

This can be life-threatening at times of severe physiologic stress (e.g., surgery, trauma, or systemic infection).

High levels of glucocorticoids are required to survive severe stress and because adrenal suppression prevents production of endogenous glucocorticoids,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

At times of stress, what must patients with adrenal suppression be given?

A

Because high levels of glucocorticoids are required to survive severe stress and because adrenal suppression prevents production of endogenous glucocorticoids, **patients must be given increased doses of oral or IV glucocorticoids at times of stress.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

When is adrenal suppression also a concern?

A

Adrenal suppression is also a concern when

  1. discontinuing prolonged use of oral glucocorticoids or
  2. when transferring from an oral route to an inhaled route.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

It take months for full adrenal functioning, during that time, what must patients do?

A

it is important to decrease the dosage gradually. Throughout this time, all patients, including those switched to inhaled glucocorticoids, must be given supplemental oral or IV glucocorticoids at times of severe stress.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

How are inhaled glucocorticoids administered?

A

Inhaled glucocorticoids are administered on a regular schedule—not PRN.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Leukotriene receptor antagonists (LTRAs)

A

Leukotriene receptor antagonists (LTRAs) suppress the effects of leukotrienes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Leukotrienes

A

Compounds that promote smooth muscle constriction, blood vessel permeability, and inflammatory responses through direct action and through recruitment of eosinophils and other inflammatory cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

In patients with asthma, how do (LTRAs) work?

A

In patients with asthma, these drugs can decrease bronchoconstriction and inflammatory responses such as edema and mucus secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Three LTRAs available and how are they taken?

A
  1. Zileutin
  2. Zafirlukast
  3. Montelukast

**taken orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

How do current guidelines recommend taking leukotriene receptor antagonists?

A
  1. second-line therapy if an inhaled glucocorticoid cannot be used and
  2. as add-on therapy when an inhaled glucocorticoid alone is inadequate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Zileuton- what does it do and what is it approved for?

A

What is does: Blocks leukotriene synthesis

Approved for: Asthma prophylaxis and maintenance therapy in adults and kids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Why can’t zileuton not be used during an attack?

A

Because effects are not immediate, zileuton cannot be used to abort an ongoing attack.

53
Q

What are zileutons less effective than?

A

Zileuton is less effective than an inhaled glucocorticoid alone and appears to be less effective than a long-acting inhaled beta2 agonist

54
Q

Major adverse effects of LTRAs

A

TRAs can cause adverse neuropsychiatric effects, including depression, anxiety, agitation, abnormal dreams, hallucinations, insomnia, irritability, restlessness, and suicidal thinking and behavior.

55
Q

What do Zafirlukast and Montelukast do?

What does Zileuton do?

A

Zafirlukast and montelukast: Block leukotriene receptors

Zileuton: blocks leukotriene synthesis

56
Q

What is the most commonly used leukotriene modulator?

A

Montelukast

57
Q

What is the Mast Cell Stabilizer Drug?

A

Cromolyn

58
Q

Cromolyn (Mast Cell Stabilizer)

A

Cromolyn is an inhalational agent that suppresses bronchial inflammation.

59
Q

What is Cromolyn used for?

A

The drug is used for prophylaxis—not quick relief—in patients with mild to moderate asthma.

60
Q

How do the antiinflammatory effects of Cromolyn compare with glucocorticoids?

A

Antiinflammatory effects are less than with glucocorticoids; therefore cromolyn is not a preferred drug for asthma therapy.

61
Q

What is the mechanism of action of Cromolyn?

A

Cromolyn suppresses inflammation; it does not cause bronchodilation.

62
Q

What do Cromolyn do to mast cells?

A

Drug acts in part by stabilizing the cytoplasmic membrane of mast cells, preventing release of histamine and other mediators. In addition, cromolyn inhibits eosinophils, macrophages, and other inflammatory cells.

63
Q

How is Cromolyn administered (route and frequency)?

A

By nebulizer

When administered on a fixed schedule, cromolyn reduces both the frequency and intensity of asthma attacks.

64
Q

What is the safest of all antiasthma medications?

A

Cromolyn

65
Q

Adverse effects of Cromolyn?

A

Cough

Bronchospasm

66
Q

What are the newest drug category for management of airway inflammation? What do the meds end it?

A

Monoclonal Antibodies

End in ‘mab’

67
Q

What do bronchodilators do?

A

Bronchodilators provide symptomatic relief in patients with asthma and COPD but do not alter the underlying inflammation that is part of the disease process.

68
Q

When is monotherapy with a bronchodilator appropriate?

A

Monotherapy with a bronchodilator is appropriate only when asthma is very mild and attacks are infrequent.

69
Q

What are the most effective drugs available for relieving acute bronchospasm and preventing EIB?

A

Inhaled beta2 agonists

70
Q

What is the mechanism of action of beta 2 agonists?

A

The beta2 agonists are sympathomimetic drugs that activate beta2-adrenergic receptors.

71
Q

By activating beta 2 receptors in smooth muscle of the lung, what do beta 2 agonists do?

A

By activating beta2 receptors in smooth muscle of the lung, these drugs promote bronchodilation and thus relieve bronchospasm.

72
Q

What do beta 2 agonists do with histamine?

A

Beta2 agonists have a limited role in suppressing histamine release in the lung and increasing ciliary motility.

73
Q

How are beta agonists administered?

A

Orally or inhalation

74
Q

Beta agonists inhaled agents, what are the groups?

A
  1. Short Acting Beta Agonists (SABA)
  2. Long-Acting Beta Agonists
75
Q

What are SABA taken for?

A
  1. taken PRN to abort an ongoing attack.
  2. In patients with EIB, they are taken before exercise to prevent an attack from occurring.
76
Q

For hospitalized patients undergoing a severe acute attack, what is the traditional treatment choice?

A

For hospitalized patients undergoing a severe acute attack, a nebulized SABA is the traditional treatment of choice

77
Q

For patients in a outpatient setting undergoing a severe acute attack, how should SABA be administered?

A

SABA delivered with an MDI

78
Q

What are considered life saving medications?

A

SABA

79
Q

What happens if SABA is taken in excess?

A

tachydysrthmias

angina

seizures

Cardiac arrest

Death

80
Q

How are LABA administered?

A

Dosing is done on a fixed schedule, not PRN.

81
Q

What is preferred for patient with stable COPD?

A

LABAs are preferred over SABAs for patients with stable COPD.

82
Q

In patients with asthma, how should LABAs be taken?

A

In patients with asthma, however, LABAs are not first-line therapy, and they must always be combined with a glucocorticoid.

83
Q

Why is LABA use alone contraindicated in asthma?

A

Their use alone in asthma is contraindicated because LABA monotherapy has been associated with increased incidence of asthma-associated death.

(Although using a LABA alone is contraindicated for patients with asthma, LABAs can still be used alone in patients with COPD).

84
Q

Systemic negative effects of SABAs?

A

Tachycardia, angina, and tremor—can occur but are usually minimal.

85
Q

Example of Methylxanthines

A
  1. Theophylline
  2. Caffeine
  3. Aminophylline
86
Q

The most prominent actions of Methylxanthines?

A
  1. (1) central nervous system (CNS) excitation and

(2) bronchodilation.

  1. Other actions include cardiac stimulation, vasodilation, and diuresis.
87
Q

What is the principal methylxanthine employed for asthma?

A

Theophylline

88
Q

Benefits of Theophylline derive primarily from what?

A

Bronchodilation

89
Q

Why must dosage of Theophylline be carefully controlled?

A

Theophylline has a narrow therapeutic range, so dosage must be carefully controlled.

90
Q

What is the mechanism of action of Theophylline?

A

Theophylline produces bronchodilation by relaxing smooth muscle of the bronchi.

91
Q

Safe dosing range of theophylline:

A

theophylline levels between 10 and 20mcg/mL.

92
Q

Theophylline levels between 20 to 25 produce what?

A

20 to 25mcg/mL, relatively mild reactions occur (e.g., nausea, vomiting, diarrhea, insomnia, restlessness).

93
Q

Theophylline levels above 30?

A

Serious adverse effects are most likely at levels above 30mcg/mL. These reactions include severe dysrhythmias (e.g., ventricular fibrillation) and convulsions that can be highly resistant to treatment. Death may result from cardiorespiratory collapse.

94
Q

What to do it theophylline toxicity is evident?

A
  1. Dosing of theophylline should stop
  2. Administer activated charcoal together with a cathartic (decreases absorption)
  3. Ventricular dysrhythmias respond to lidocaine/amiodarone
  4. IV benzo controls seizures
95
Q

Drugs interactions with Theophyllines?

A
  1. Caffeine
  2. Tobacco and marijuana
  3. Cimetidine
  4. Fluoroquinolone antibiotics
96
Q

Caffeine + Theophylline

A

Caffeine can intensify the adverse effects of theophylline on the CNS and heart.

In addition, caffeine can compete with theophylline for drug-metabolizing enzymes, causing theophylline levels to rise.

97
Q

Tobacco and Marijuana + Theophylline

A

Smoking tobacco or marijuana can induce theophylline metabolism, resulting in increased drug clearance.

98
Q

cimetidine and the fluoroquinolone antibiotics + theophylline

A

Can elevate plasma levels of theophylline primarily by inhibiting hepatic metabolism

99
Q

How is theophylline available for use?

A

IV or oral use

100
Q

When is IV theophylline used? How should it be administered?

A

Emergencies

Administration must be done slowly because rapid injection can cause fatal cardiovascular reactions.

101
Q

Aminophylline (Methylxanthines)

A

Aminophylline is a theophylline salt that is considerably more soluble than theophylline itself.

102
Q

How do anticholinergic drugs work? What are they approved for?

A

Anticholinergic drugs improve lung function by blocking muscarinic receptors in the bronchi, reducing bronchoconstriction.

These drugs are approved only for COPD.

103
Q

First anticholinergic drug:

A

Ipatoptrium

104
Q

Ipratoprium mechanism of action

A

Like atropine, ipratropium is a muscarinic antagonist. By blocking muscarinic cholinergic receptors in the bronchi, ipratropium prevents bronchoconstriction.

105
Q

How does ipratropium compare to beta2 agonists?

A

Is less effective than the beta2 agonists.

Because ipratropium and the beta2-adrenergic agonists promote bronchodilation by different mechanisms, their beneficial effects are additive.

106
Q

When do therapeutic effects of ipratropium begin?

A

Therapeutic effects begin within 30seconds, reach 50% of their maximum in 3minutes, and persist about 6hours.

107
Q

Most common adverse effects of ipratropium?

A

Dry mouth and irritation of the pharynx.

108
Q

Tiotropium

A

Tiotropium is a LAMA approved for maintenance therapy of bronchospasm associated with COPD.

Not approved for asthma but has been used off-label for patients who have not responded to other medications.

109
Q

How does ipratropium compare to tiotropium?

A

Compared with ipratropium, tiotropium is more effective and has a more convenient dosing schedule (once daily vs. 4 times daily).

110
Q

What is tiotropium indicated for?

A

Tiotropium is indicated only for long-term maintenance.

111
Q

When do therapeutic effects of tiotropium begin?

A

Therapeutic effects begin about 30minutes after inhalation, peak in 3hours, and persist for about 24hours.

With subsequent doses, bronchodilation gets better and better, reaching a plateau after eight consecutive doses (8 days).

112
Q

The goals for stopping acute severe exacerbations of asthma?

A
  1. to relieve airway obstruction and hypoxemia and
  2. to normalize lung function as quickly as possible.
113
Q

Two ways in which pharmacological drugs for asthma and COPD can be taken:

A
  1. Inhaled
  2. Systemic
114
Q

Anti inflammatory drugs include:

A
  1. Glucocorticoids
  2. Leukotriene antagonists
  3. Mast cell stabilizer
  4. Monoclonal antibodies
115
Q

Bronchodilators include:

A
  1. Beta 2 agonists
  2. Anticholinergic
  3. Methylxanthine (theophylline)
116
Q

Three obvious advantages of inhaled glucocorticoids:

A
  1. Therapeutic effect are enhanced
  2. Systemic effects are minimized
  3. Relief rapid of acute attacks
117
Q

Three types of inhalers:

A
  1. Metered Dose inhalers (MDIs)
  2. Dry Powder Inhalers
  3. Nebulizers
118
Q

What is considered the most effective antiasthma drug available?

A

inhaled glucocorticoids

119
Q

What are Inhaled Glucocorticoids used for:

A

Prophylaxis of chronic asthma

120
Q

When should Glucocorticoids be taken?

A

Dosing must be on a fixed schedule, not as needed (PRN)

121
Q

When are inhaled Glucocorticoids NOT used

A

Not used to abort an ongoing attack

122
Q

Why are inhaled Glucocorticoids not useful during an ongoing attack?

A

Not used to abort on ongoing attack because beneficial effects develop slowly

123
Q

Systemic Glucocorticoids- how are they taken/

A

IV or orally

124
Q

When are Systemic Glucocorticoids used?

A
  1. For pts with moderate to severe persistent asthma
  2. for management of acute exacerbations of asthma or COPD
125
Q

Why are systemic Glucocorticoids dangerous?

A

Potential for toxicity

126
Q

Since systemic glucocorticoids have a potential for toxicity, when should they be used?

A

Should only be used when symptoms cannot be controlled with safer medications (inhaled glucocorticoids, inhaled beta 2 agonists)

127
Q

How long should systemic glucocorticoids be used?

A

Treatment should be as brief as possible

128
Q

Adverse Effects of systemic glucocorticoids:

A

1.Short term therapy

  1. Long term therapy
  2. Adrenal suppression
  3. Osteoporosis
  4. Hyperglycemia
  5. Peptic ulcer disease
  6. Growth suppression
129
Q

Glucocorticoids reduce respiratory symptoms by suppressing inflammation. Specific antiinflammatory effects include:

A

*Decreased synthesis and release of inflammatory mediators (e.g., leukotrienes, histamine, prostaglandins)

*Decreased infiltration and activity of inflammatory cells (e.g., eosinophils, leukocytes)

*Decreased edema of the airway mucosa (secondary to a decrease in vascular permeability)